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Approaches to improving agricultural crops have relied on either mutational or traditional 
breeding and selection methods or through the random introduction of novel genes 
into crops by transformation (e.g. using Agrobacterium). These approaches are inherently 
time-consuming, inefficient and expensive, especially for developing complex, multi-trait 
products that are now standard for the industry. To better serve the market, new technolo-
gies have been developed that focus on targeted genome editing. One such technology is 
Dow AgroSciences’ EXZACTTM Precision Technology that facilitates precise changes in 
plant genomes including DNA deletions, edits (point mutations) and targeted gene addi-
tions (trans-, cis-, intra-). Using EXZACTTM Precision Technology, developers and breeders 
can now introduce genetic traits more efficiently and precisely than ever before. 
EXZACTTM Precision Technology is based on zinc-finger nucleases (ZFNs) that are 
composed of a DNA-binding domain (zinc-finger proteins) and a nuclease domain derived 
from the restriction endonuclease Fok1. DNA binding is mediated by ZF modules, 
where each ZF recognizes a specific three-base-pair DNA sequence. Typically four to six 
individual ZFs are linked together for specific recognition of a unique DNA sequence 
(12–18 nucleotides) (Figure 1). The Fok1 nuclease that generates the specific double-
stranded DNA cleavage at the targeted DNA sequence requires dimerization of the two 
Fok1 domains for cleavage activity. Therefore, functional ZFNs are dimeric proteins 
consisting of two unique zinc-finger proteins (Figure 1) that bind to two unique DNA 
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sequences (24–36 nucleotides) in the correct orientation, at the same time, to generate a 
targeted double-strand DNA break.
The EXZACTTM Precision Technology platform exploits the functionality of ZFNs 
and plant cellular DNA-repair mechanisms to facilitate targeted deletions (ZFN-1), 
editing (ZFN-2) and addition (ZFN-3) of DNA (or genes) in model and specialty-crop 
species. When ZFNs are delivered into plant cells, they bind to a specific, predetermined 
genomic sequence and introduce a DNA double-strand break that activates the innate 
cellular DNA-repair pathways. Repair by non-homologous end-joining (NHEJ) may 
result in the creation of small insertions or deletions (INDELS) at the break site, leading 
to targeted mutagenesis and effective disruption of the genomic sequence (Figure 1). If 
the initial target sequence is a gene, NHEJ-induced targeted mutagenesis leads to loss-
of-function or altered-function alleles. The double-stranded DNA breaks can also be 
repaired by homology-directed repair (HDR) in the presence of a donor DNA molecule 
with homology to the break site, resulting in targeted donor addition. With the HDR, 
presence of a gene of interest (GOI) in the donor leads to targeted gene addition, whereas 
point mutations in the donor give rise to a genome-editing mutation (Figure 1).
Figure 1. Model of ZFN DNA cleavage and repair in the presence (HDR pathway) or 
absence (NHEJ pathway) of a DNA-repair template. Depending on the DNA-repair 
pathway and repair donor-DNA template, genomic deletions, edits or additions can be 
generated, screened and selected.
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EXZACTTM targeted gene addition offers several benefits for trait-product develop-
ment compared to conventional methods. With current transformation methods, a GOI 
is randomly inserted in the plant genome and screening for events of interest is time-, 
resource- and cost-intensive. In contrast, targeted gene addition to a specific, desired lo-
cus, such as a safe harbor location (see Genomic Locations below) is expected to generate 
higher-quality events with minimal unintended side-effects and an increased probability 
of achieving the desired product. In addition, targeting to a specific locus simplifies 
analytics involved in event characterization and sorting, thus reducing trait-development 
cycle times.
An additional advantage of gene addition is that GOIs can repeatedly be targeted to 
the same safe-harbor location to generate new events, reducing costs over time through 
the reuse of targeting reagents, analytics and potentially regulatory and introgression 
processes. Gene addition also provides new options for stacking, to generate multi-gene, 
multi-trait products. Currently, stacking traits is primarily achieved by breeding together 
multiple traits from single events located at various loci in the plant genome. However, 
as the number of traits being bred or stacked into a single product increases, efficiency of 
stacking decreases due to the increased likelihood of the various loci segregating during the 
breeding process. Using ZFNs, it is possible to target multiple genes to the same location, 
which decreases the number of loci involved in breeding and facilitates multi-trait product 
development. It is also feasible to use ZFNs to add genes to existing commercial-grade 
events to generate new gene stacks to meet customer and market needs.
Figure 2. EXZACTTM Precision Technology platform. Donor design, delivery, analytics 
and genome-location information was coupled with DNA double-strand break genera-
tion ability to create an operable platform for trait applications.
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EXZACTTM Precision Technology Platform
To optimize and enhance EXZACTTM technology for trait-product development, an 
EXZACTTM Precision Technology platform has been developed (Figure 2). This platform 
consists of companion technologies including DNA-donor design and delivery, analytics, 
identification and optimization of gene-targeting genomic locations and advancements in 
ZFN-targeting technology. The combined suite of technologies making up the EXZACTTM 
Precision Technology platform has been developed in several crop species including maize, 
soybean, canola and wheat.
Figure 3. Activity of a ZFN in maize cells. DNA-cleavage activity of ZFNs is measured 
by the presence of INDELs (-----) using illumine sequencing. The bar with the star 
represents the cleavage site for the ZFN. The reference target sequence is shown at the 
top and sequences with INDELs from Illumina® are shown in dark gray.
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Targeting Technologies: ZFN Design and Testing
ZFN design and testing capability is critical for a robust genome-editing program. Func-
tional ZFNs have been developed for targets in a number of model and crop species for 
gene addition, deletion and editing applications (Cai et al., 2009; Shukla et al., 2009; 
Ainley et al., 2013).
With advancements in ZF designs, ZFNs can now be effectively developed for DNA 
targets less than 100 bp and have been linked to enhanced (obligate heterodimeric) Fok1 
nuclease domains to reduce the potential of off-target cleavage (Doyon et al., 2011). An 
agreement between Dow AgroSciences and Sigma Aldrich has been developed for plant-
ZFN design and supply to meet product-scale needs.
In addition to improved ZFN designs, prior to deploying EXZACTTM ZFNs in plants, 
3–16 ZFN designs are typically generated per DNA target and assayed for their ability to 
generate targeted DNA double-stranded breaks. Lead-candidate designs are identified by 
transient expression in plant cells followed by deep sequencing of genomic DNA from 
ZFN-treated and control materials. Delivery of ZFNs into cells leads to DNA double-
Figure 4. Analytical process for identifying targeted events.
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strand breaks that are repaired by NHEJ, which leaves an INDEL footprint at the break 
site. Presence of, and number of, sequences with INDELS is a measure of ZFN activity. 
A diverse INDEL footprint, as seen by the presence of different types of deletions, further 
indicates effectiveness of a ZFN. A representative activity profile for a maize target-specific 
ZFN is shown in Figure 3.
As a result of improved EXZACTTM ZF design, use of obligate heterodimeric Fok1 
nucleases and screening of designed ZFNs for DNA-binding and -cleavage activity, the 
resulting EXZACTTM ZFNs deployed for gene deletion, addition or editing result in 
highly efficacious ZFNs with minimal off-target cleavage and superior results. 
Analytical Technologies
Analytical technologies are foundational to the success of the EXZACTTM technology. In 
most plant-cell-targeting studies, targeted gene integration occurs in conjunction with 
random integration. Therefore, there is a need for sensitive methods for rapid identifica-
tion of only targeted events. A tiered molecular process has been developed that uses 
two PCR-based screens for rapid identification of putative targeted events that are then 
confirmed by higher resolution methods, including Southern analysis and next-generation 
sequencing (Figure 4). PCR screens are designed to measure both intact ZFN-binding sites 
at a target locus and also score for the presence of the GOI at the target site by junctional 
in-out PCR (Ainley et al., 2013). The duplicate screens are done in parallel to reduce false 
positives and increase the robustness of targeted event identification.
Delivery and Donor-Design Technologies
Ability to effectively co-deliver ZFN and donor constructs is critical for achieving targeted 
genome addition. In maize, targeted gene addition has been achieved successfully by deliv-
ering ZFN and donor constructs using WHISKERSTM and microparticle bombardment 
(Shukla et al., 2009; Ainley et al., 2013). In addition to DNA delivery, donor constructs 
have been optimized for efficient and optimal HDR of the targeted double-stranded break 
through the use of 750- to 1,000-bp homology sequences flanking the GOI. 
Genomic Location
In a plant genome, not all locations are suitable for targeted gene insertion. Safe-harbor 
locations are genomic regions where transgenes can be added with minimal unintended 
side effects and for consistent, reproducible transgene performance. Such safe-harbor 
locations can be identified through previously characterized transgenic plants. Event-32 
is a Dow AgroSciences’ pipeline event that was generated by standard transformation of 
maize with a corn-rootworm-resistant/herbicide-tolerant gene stack. The event performed 
well in the field as demonstrated by stable trait expression and efficacy, and exhibited 
neutral agronomics and good breeding characteristics. Because of these features, the 
transgene-insertion site of the event was classified as a potential safe-harbor location. 
This safe-harbor location has since been retargeted in a Hi-II maize background using a 
custom-designed ZFN (ZFN6) and a GOI by HDR (Figure 5). As a result of improved 
ZFN designs, screening and analytic methods, targeting frequencies of 2% have repeatedly 
been achieved at this safe-harbor location.
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Gene Stacking
For stacking multiple genes at a single location using EXZACTTM technology, a suite of 
engineered ZFNs (eZFNs) and EXZACTTM landing pads (ELPs) have been developed 
(Ainley et al., 2013) (Figure 6). ELPs are unique DNA sequences that carry an eZFN 
DNA-binding sequence flanked with DNA sequences homologous to an incoming donor 
DNA sequence. For stacking, an ELP with a first GOI is pre-integrated into the plant 
genome (e.g. E32 safe harbor); subsequent delivery of a donor carrying a second GOI 
and an appropriate eZFN leads to a DNA double-strand break at the ELP and inser-
tion of the donor via HDR, resulting in stacking of the two genes of interest (Figure 
6). Presence of a second ELP in the incoming donor allows addition of a third GOI, 
and so on. This strategy has been used to stack two herbicide-tolerant genes, PAT and 
aryloxyalkanoate dioxygenase 1 (AAD-1) in maize. The stacked genes were functional 
Figure 5. Targeted gene addition at the Event-32 locus.
A GOI was inserted at the E32 locus using EXZAT™ technology.
E32 left/right: sequences homologous to the E32 locus.
ZFN6: E32 locus-specific ZFN.
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Figure 6. Transgene stacking with EXZACT™ landing pads.
at expression and phenotypic levels and co-segregated as expected (Ainley et al., 2013). 
The stacking strategy allows insertion of multiple genes at a single location to facilitate 
multi-trait product development.
The EXZACTTM Precision Technology platform is a new way of thinking about 
 agricultural biotechnology, and represents a departure from conventional breeding 
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 methods.  Targeted gene deletion, editing and addition have been demonstrated in 
tobacco, maize, canola, tomato and wheat. In maize, targeting to an endogenous locus 
(IPK1) as well as stacking of herbicide-tolerant traits at an engineered locus have been 
achieved (Shukla et al., 2009; Ainley et al., 2013).
External Collaborations
EXZACTTM Precision Technology is available and accessible both to the public and pri-
vate sectors through a Dow AgroSciences’ licensing agreement. Like the private sector, 
public-sector breeders and scientists have significant opportunities to employ EXZACTTM 
Precision Technology in their breeding programs, especially in minor crops. Dow Agro-
Sciences has entered into several licensing agreements with partners around the world to 
develop targeted gene improvements ranging from deletions, edits and gene insertions 
in row, community and specialty crops such as maize, canola, cassava, wheat, tobacco, 
tomato and forestry trees.  
As an example, the Department of Environment and Primary Industries (DEPI) of 
the State of Victory, Australia, through its commercial arm, Agriculture Victoria Services 
Pty Ltd. (AVS), strengthened a collaborative agreement to improve the performances of 
Australian canola varieties. The project uses the EXZACTTM Precision Genome Editing 
Technology platform to continue developing new varieties of canola with enhanced 
performance designed to benefit farmers in Australia and globally. In addition, AVS will 
also use the EXZACTTM Precision Genome Editing Technology platform to enhance the 
genetics of crops important to Australian primary producers.
Through valuable collaborative efforts, a variety of improved crop varieties is being 
developed with value-adding traits ranging from more-nutritious and insect-resistant 
cassava and higher-yielding tomatoes, to oil crops with healthier, improved oil profiles 
and crops with improved herbicide tolerance.
Advances in custom ZFN designs, high resolution analytics, novel donor designs, 
 delivery technologies and genomics will continue to expand the utility of the EXZACTTM 
Precision Technology for trait discovery and product development. Benefits of targeting 
genes, genomic deletions and edits at desired locations in plant genomes will continue 
to be realized, resulting in reduced cycle times and costs for developers while resulting in 
improved, high-value crops for the farmer and consumer.
Regulatory Considerations
ZFN applications are simply innovative improvements and refinements of traditional 
breeding methods used to optimize plant health, nutritional quality and yield. Changes 
and variation in plant genomes (e.g. mutations, chromosome rearrangements) are ubiq-
uitous and essential drivers for plants to adapt to their environment and have resulted 
in a wide variety of crops with a long history of safe use. In fact, over the past century, 
mutagenesis applications (e.g. chemical and radiation mutagenesis) have resulted in over 
3,200 beneficial crop varieties that have been planted and safely consumed worldwide in 
over 175 species (IAEA, 2010). In addition, once developed, traditional breeding pro-
cesses are deployed to efficiently breed desired mutations into elite plant varieties while 
minimizing the donors’ genetic background. 
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Due to the controlled, precise manner of the EXZACTTM Precision Technology plat-
form, only the desired genomic changes (gene introduction, deletion or edit) are introduced 
into the plant genome and the resulting trait can be bred into commercial crops more 
efficiently and rapidly compared to traditional breeding and mutational applications. 
In addition to the considerable research and development advantages, EXZACTTM 
Precision Technology offers potentially significant regulatory advantages for products 
resulting from both targeted gene addition (ZFN-3) and targeted mutations (ZFN-1,-
2). Globally, regulatory oversight of biotech products is a time-consuming and expensive 
endeavor estimated at $35 million with an average of six years for regulatory approval / 
deregulation (Phillips McDougall, 2011). As a result, most biotech crops developed to 
date have been limited to a handful of traits and high production-acre commodity crops 
where a return on the investment can be realized (James, 2013).
Through targeted precise addition (ZFN-3), unintended effects (yield drag, gene 
silencing) often associated with random gene integration, can be avoided. By precisely 
knowing the location of the introduced trait in the plant’s genome, EXZACTTM will help 
researchers and regulators better understand the end product and help develop a more 
efficient, less costly and less time-consuming regulatory process (FSANZ, 2013).  
Like traditional mutagenesis techniques, EXZACTTM Precision Technology delete 
(ZFN-1) and edit (ZFN-2), can induce changes in the DNA analogous to chemical mu-
tagens, but with the benefit of targeting the mutation to a predetermined location in the 
plant genome. Traditional mutagenesis techniques are used to induce point mutations or 
small insertions / deletions and are intrinsically very non-specific, in which thousands of 
nucleotides are mutated instead of a desired single nucleotide. Additionally, traditional 
mutagenesis techniques can often result in genetic alterations at multiple genomic loca-
tions. As a result, years of breeding are required to eliminate undesired mutations and to 
cross the desired mutation into an elite commercial crop variety.  
Through EXZACTTM Precision Technology delete (ZFN-1) and edit (ZFN-2) ap-
plications, breeders can now take advantage of a plant’s own natural genetic variability, 
allowing precise mutations to be made at predefined locations in the genome, resulting in 
beneficial, desired mutational traits that can be bred into commercial crops more rapidly 
compared to traditional mutational applications. As with traditional mutational products, 
EXZACTTM Precision Technology mutational applications do not involve recombinant 
DNA and result in products that are similar, and in many cases indistinguishable, from 
conventionally bred or traditional mutagenesis products.  
Based on these facts, it has been concluded by USDA-APHIS that EXZACTTM Preci-
sion Technology delete products fall outside their scope of regulation (USDA APHIS, 
2014). In addition, an Australian scientific panel convened by Food Standards Australia 
New Zealand concluded that ZFN-1 and ZFN-2 do not present a significantly greater 
food-safety concern than other forms of mutagenesis. Such changes are small and defin-
able with predictable outcomes and the panel concluded that food derived from such 
applications would be similar to food produced using traditional mutagenic techniques, 
and should, therefore, not be regarded as GM (FSANZ, 2013).
Efforts are underway to help facilitate and assist global regulatory decision making 
around products developed through various gene-editing applications. Gene-editing 
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techniques used to develop new plant varieties do not pose a specific safety hazard; 
rather, the characteristics of the plant determine its safety. Thus, the need to regulate 
plants developed through gene-editing techniques should be driven by the characteristics 
of the product (i.e. whether it is materially different from existing products present in 
food, feed or the environment) rather than by the method or process used to make that 
product. In addition, governments should avoid regulating products developed through 
gene-editing applications that are similar to, or indistinguishable from, products result-
ing from traditional breeding methods, since they do not differ in their safety (CropLife 
International, 2014). 
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